Biophytis Financials
| ALBPS Stock | EUR 0.30 0.01 3.45% |
Biophytis |
Understanding current and past Biophytis Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Biophytis' financial statements are interrelated, with each one affecting the others. For example, an increase in Biophytis' assets may result in an increase in income on the income statement.
Biophytis Stock Summary
Biophytis competes with Cellectis, and Innate Pharma. Biophytis SA, a clinical-stage biotechnology company, focuses on the development of therapeutics that slow the degenerative processes and improve functional outcomes for patients suffering from age-related diseases. The company was founded in 2006 and is headquartered in Paris, France. BIOPHYTIS operates under Biotechnology classification in France and is traded on Paris Stock Exchange. It employs 30 people.| Instrument | France Stock View All |
| Exchange | Euronext Paris |
| ISIN | FR0012816825 |
| Business Address | Sorbonne University, Paris, |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.biophytis.com |
| Phone | 33 1 44 27 23 00 |
| Currency | EUR - Euro |
You should never invest in Biophytis without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Biophytis Stock, because this is throwing your money away. Analyzing the key information contained in Biophytis' financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Biophytis Key Financial Ratios
Biophytis' financial ratios allow both analysts and investors to convert raw data from Biophytis' financial statements into concise, actionable information that can be used to evaluate the performance of Biophytis over time and compare it to other companies across industries.Biophytis Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Biophytis's current stock value. Our valuation model uses many indicators to compare Biophytis value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Biophytis competition to find correlations between indicators driving Biophytis's intrinsic value. More Info.Biophytis SA is rated third in return on equity category among its peers. It also is rated third in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Biophytis' earnings, one of the primary drivers of an investment's value.Biophytis SA Systematic Risk
Biophytis' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Biophytis volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on Biophytis SA correlated with the market. If Beta is less than 0 Biophytis generally moves in the opposite direction as compared to the market. If Biophytis Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Biophytis SA is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Biophytis is generally in the same direction as the market. If Beta > 1 Biophytis moves generally in the same direction as, but more than the movement of the benchmark.
Biophytis December 1, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Biophytis help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Biophytis SA. We use our internally-developed statistical techniques to arrive at the intrinsic value of Biophytis SA based on widely used predictive technical indicators. In general, we focus on analyzing Biophytis Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Biophytis's daily price indicators and compare them against related drivers.
| Information Ratio | (0.22) | |||
| Maximum Drawdown | 21.59 | |||
| Value At Risk | (8.33) | |||
| Potential Upside | 3.45 |
Additional Tools for Biophytis Stock Analysis
When running Biophytis' price analysis, check to measure Biophytis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biophytis is operating at the current time. Most of Biophytis' value examination focuses on studying past and present price action to predict the probability of Biophytis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biophytis' price. Additionally, you may evaluate how the addition of Biophytis to your portfolios can decrease your overall portfolio volatility.